What is Regenics?
Regenics operates as a specialized medical clinic dedicated to providing advanced regenerative therapies. Their core offerings encompass hormone optimization, medical weight loss programs, intravenous (IV) therapy, and aesthetic treatments. The clinic emphasizes a personalized approach, developing provider-led protocols grounded in clinical evidence to address each patient's unique biological profile and health objectives. By integrating comprehensive biomarker testing and focusing on testosterone optimization, Regenics aims to significantly enhance patient vitality and overall well-being, offering tailored solutions for weight management, sexual wellness, and anti-aging.
How much funding has Regenics raised?
Regenics has raised a total of $26K across 1 funding round:
Debt
$26K
Debt (2021): $26K with participation from PPP
What's next for Regenics?
With significant Series B/C stage backing and recent capital earmarked for expansion, Regenics is poised for a period of intensified growth and service enhancement. The company's strategic focus on evidence-based regenerative medicine and personalized patient care suggests a trajectory aimed at broadening its market reach and deepening its therapeutic impact. Future developments are likely to involve scaling operational capacity, potentially expanding service lines, and further leveraging technology to optimize treatment outcomes and patient engagement. This investment will be critical in solidifying Regenics' position as a leader in advanced wellness solutions.
See full Regenics company page
